Table 3.
Systolic Blood Pressure (mean ± SD) After Weekly i.v. Administration (40 mg Iron/kg Body Weight or Equivalent Volume) in ISS, ISORIG and Control Groups Over a 4-Week Period
| Day | ISSFERP (n = 10) | ISSFERI (n = 10) | ISSFERO (n = 10) | ISSENCI (n = 10) | ISSBACK (n = 10) | ISSLIB (n = 10) | ISORIG (n = 10) | Control (n = 10) |
|---|---|---|---|---|---|---|---|---|
| 0 | 118.1 ± 2.4 | 119.0 ± 2.9 | 118.1 ± 2.4 | 119.0 ± 2.9 | 118.1 ± 2.3 | 119.1 ± 2.9 | 118.9 ± 2.2 | 118.9 ± 1.9 |
| 1 | 112.3 ± 1.9 | 111.0 ± 0.1 | 112.3 ± 1.9 | 114.1 ± 1.9 | 112.3 ± 1.9 | 112.0 ± 1.9 | 116.2 ± 2.0# | 120.2 ± 0.5* |
| 8 | 111.4 ± 1.7 | 112.0 ± 3.1 | 114.7 ± 1.7 | 113.6 ± 3.1 | 114.7 ± 1.7 | 110.1 ± 3.1 | 117.8 ± 2.8# | 119.8 ± 2.1# |
| 15 | 112.6 ± 1.8 | 111.1 ± 2.4 | 114.9 ± 1.8 | 114.1 ± 2.4 | 116.8 ± 1.8 | 114.7 ± 2.4 | 118.0 ± 2.2# | 120.3 ± 2.1# |
| 22 | 113.7 ± 2.0 | 114.2 ± 2.5 | 114.5 ± 2.0 | 112.1 ± 2.5 | 114.5 ± 2.0 | 113.9 ± 2.5 | 119.4 ± 1.9# | 120.3 ± 2.0# |
| 29 | 115.1 ± 1.8 | 114.8 ± 3.0 | 113.6 ± 2.5 | 114.7 ± 2.6 | 113.7 ± 2.0 | 113.8 ± 3.0 | 121.2 ± 2.6# | 122.1 ± 2.4# |
*
p< 0.01 versus all groups
#
p< 0.01 versus ISSFERP, ISSFERI, ISSFERO, ISSENCI, ISSBACK, ISSLIB